|
1
|
- Examining Mr. Jones As A Case Study
- Kurt Takamine
- Term A, 2006
- PSYC 328 Michael McGuire, Ph.D.
|
|
2
|
- Introductory Remarks
- Current Treatment Approaches and Options
- Case Study of Mr. Jones, the movie
- Analysis of Bipolar Disorder Depiction in Mr. Jones
- Concluding Remarks
- References
|
|
3
|
- Bipolar Disorders are characterized by alternating:
- Major depressive episodes
- Manic or hypomanic episodes
- When the depression and mania (periods of elation are extreme Bipolar I
- When the depression and mania are not so extreme Bipolar II
|
|
4
|
- In the Depressive Phase, must exhibit four of these symptoms for at
least two weeks
|
|
5
|
- In the Manic Phase, must exhibit three of these symptoms for at least
one week unless hospitalized
|
|
6
|
- Psychoeducation: The client is
taught to note the signs of an impending episode
- For both manic or depressive events
- It levels out the episode before it progresses
- It is most effective when the family members are educated as well
|
|
7
|
- Family-Focused Treatment (FFT): Rea
et al. (2003) compared FFT with Individual Therapy
- Only 12% of FFT clients were re-hospitalized
- 60% of Individual Therapy were re-admitted
- Perlick et al. (2004) confirmed this
|
|
8
|
- Cognitive Behavioral Therapy (CBT)
- Wright et al. (2005) found that:
- CBT protected clients from depressive episodes for 30 months
- CBT protected clients from mania for 12 months
- It was not clear why the prevention of mania was only effective for 12
months
|
|
9
|
- Interpersonal Therapy (IT) and Social Rhythm Therapy (SRT):
- Both therapies allow clients to regulate their schedules
- Food, sleep, exercise medication are monitored to ward off episodes
- IT helps keep the client focused on moderating one’s emotions with
positive relationships
|
|
10
|
- The best results were obtained when medication and counseling were
utilized in tandem
- Mood stabalizers (e.g., Lithium or Valproate) alone or with
antidepressants were effective
- Quetinapine (Calabrese et al, 2005) was most promising as new generation
drugs for Bipolar I and II
- Suppes et al., 1999 and Thase & Sachs, 2000 studied clozapine
(Clozaril®), olanzapine (Zyprexa®), risperidone
(Risperdal®), and other antipsychotic agents for use in
clinical settings.
|
|
11
|
- Mr. Jones (Played by Richard Gere) was a Bipolar I individual (though
not classified this way in the movie)
- The movie described Mr. Jones as “manic-depressive”
- Jones was charming, talented, affable, creative, charismatic, and
promiscuous in his manic phase
- He was at times violent, and was forlorn, lifeless, and despondent
during his depressive episodes
- He resisted taking his meds (Haldol), and would often be involuntarily
hospitalized at those times
|
|
12
|
- The movie does not provide a strict time frame of events
- It does not appear that there is Rapid-Cycling between manic or
depressive phases
- The movie presents him as being suicidal (or reckless) when he stands on
a roof top
- Mr. Jones fits the profile of a Bipolar I personality
- He has a sexual affair with his therapist (Dr. “Libbie” Bowen), and she
leaves her practice because of her love for Mr. Jones
|
|
13
|
- In some ways, Mr. Jones accurately depicted Bipolar Disorder
- For example, the depressive and manic stages were depicted correctly
- Jones refused to take his meds, jeopardizing his treatment
- In other ways, there were problems in the movie
- His affair with his therapist was ethical problem
- It wasn’t clear if he was suicidal
- He was at first diagnosed with schizophrenia
- The therapy wasn’t clearly described
|
|
14
|
- Bipolar Disorder affects 1% of the population
- Treatment modalities are still being currently debated and researched
- There is promising help for these individuals, but only if they follow
the entire treatment protocol
- Mr. Jones, as a movie, was accurate in its depiction of the highs and
lows of this condition, but was questionable in its other depictions of
the mental health profession
|
|
15
|
- Would I recommend Mr. Jones as a movie describing Bipolar Disorder?
- Yes-Richard Gere’s performance makes Bipolar Disorder more
comprehendible
- However, it should be pointed out that the therapy is not explicated, so
it is not about treatment modalities
- Also, the ethical disparities are serious issues to contend with
- As long as one realizes that liberties are taken, it is a fine movie
|
|
16
|
- American Psychological Association. (2000). Diagnostic and statistical
manual of mental disorders (4-TR ed.).
Washington, DC: Author
- Blechert, J. & Meyer, T. D.
(March, 2005). Are measures of
hypomanic personality, impulsive nonconformity and rigidity predictors
of bipolar symptoms? British
Journal of Clinical Psychology, 44(1), 13-15.
- Brown, T. A., DiNardo, P. A., Lehman, C. L. & Campbell, L. A.
(2001). Reliability of DSM-IV anxiety and mood disorders: Implications
for the classification of emotional disorders. Journal of Abnormal
Psychology, 110, 49-58.
- Calabrese, J. R., Keck, P.E., Macfadden, W., Minkwitz, M., Ketter, T.A.,
Weisler, R.H., Cutler, A. J., McCoy, M., Wilson, E., & Mullen, J.
(2005). A randomized,
double-blind, placebo-controlled trial of Quetiapine in the treatment
of Bipolar I or II Depression. American
Journal of Psychiatry 162, 1351-1360.
|
|
17
|
- Dion, G. L., Tohen, M., Anthony, W. A., & Waternaux, C. S.
(1988). Symptoms and functioning
of patients with bipolar disorder six months after
hospitalization. Hospital and
Community Psychiatry, 39, 652-657.
- Figgis. Michael (Director), Jerry A. Baerwitz and Richard Gere
(Executive Producers) (1993). R.
Jones [Motion picture], Los Angeles.
- Frank, E. (1999). Interpersonal
and social rhythm therapy prevents depressive symptomatology in bipolar
I patients. Bipolar Disorders, 1(Suppl.1),
13.
- Henney, J. E. (2000). Risk of
drug interactions with St. John's wort. From the Food and Drug
Administration. Journal of the American Medical Association, 283(13):
1679.
- Moss, B. F. & Magaro, P. A. (September, 1989). Personality types and hetero- versus
auto-hypnosis. Journal of Personality and Social Psychology,
57(3), 532-538.
|
|
18
|
- National Institute of Mental Health. (2006, Feb 17). Bipolar Disorder. National Institute of Mental
Health. Retrieved March 11, 2006
from http://www.nimh.nih.gov/publicat/bipolar.cfm
- Suppes, T., Webb, A., Paul, B., Carmody, T., Kraemer, H., Rush, A. J.
(1999). Clinical outcome in a randomized 1-year trial of clozapine
versus treatment as usual for patients with treatment-resistant illness
and a history of mania. American Journal of Psychiatry, 156(8):
1164-1169.
- Thase, M. E. & Sachs, G. S.(2000).
Bipolar depression: pharmacotherapy and related therapeutic
strategies. Biological Psychiatry, 48(6), 558-572.
|
|
19
|
- Perlick, D. A., Rosenheck, R. A., Clarkin, J. F., Maciejewski, P. K.,
Sirey, J., Struening, E., Link, B. G. (September, 2004). Impact of family burden and affective
response on clinical outcome among patients with bipolar disorder. Psychiatric Services, 55(9),
1029-1035.
- Perlis, R. H., Brown, E., Baker, R. W. & Nierenberg, A. A. Clinical features
of Bipolar Depression versus Major Depressive Disorder in large
multicenter trials. The American Journal of Psychiatry, 163
(2), 225-232.
- Rea, M. M., Miklowitz, D. J., Tompson, M. C., Goldstein, M. J., Hwang,
S., & Mintz, J. (2003). Family-focused treatment versus
individual treatment for Bipolar Disorder: Results of a randomized clinical
trial, Journal of Counseling and
Clinical Psychology, 71, 482-492.
|